Comparing shingles incidence and complication rates from medical record review and administrative database estimates: How close are they?

American Journal of Epidemiology

Volumn 174, Issue 9, 2011, Pages 1054-1061

  Yawn, Barbara P ^a   Wollan, Peter ^a   St Sauver, Jennifer ^b  

^a OLMSTED MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

administrative records; data collection; epidemiologic methods; herpes zoster; incidence rates

Indexed keywords

ADULT; AGE CLASS; DATA SET; DATABASE; EPIDEMIOLOGY; ESTIMATION METHOD; HEALTH RISK; HEALTH SERVICES; TEMPORAL VARIATION; VACCINATION; VIRAL DISEASE;

ADULT; AGED; COMPARATIVE STUDY; CONTROLLED STUDY; DATA BASE; HERPES ZOSTER; HUMAN; INFECTION COMPLICATION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MORBIDITY; REVIEW; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; CONFIDENCE INTERVALS; DATABASES, FACTUAL; FEMALE; HERPES ZOSTER; HUMANS; INCIDENCE; MALE; MEDICAL RECORDS; MIDDLE AGED; MINNESOTA; NEURALGIA, POSTHERPETIC; REPRODUCIBILITY OF RESULTS; UNITED STATES; YOUNG ADULT;

MINNESOTA; OLMSTED COUNTY; UNITED STATES;

HERPES ZOSTER;

EID: 80054923604     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwr206     Document Type: Review

References (45)

1. Kimberlin DW, Whitley RJ. Varicella-zoster vaccine for the prevention of herpes zoster. N Engl J Med. 2007;356(13): 1338-1343. (Pubitemid 46513299)
2. Oxman MN. Vaccination to prevent herpes zoster and postherpetic neuralgia. Hum Vaccin. 2007;3(2):64-68. (Pubitemid 46493608)
3. Oxman MN, Levin MJ, Johnson GR, et al. Avaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352(22):2271- 2284.
4. Donahue JG, Choo PW, Manson JE, et al. The incidence of herpes zoster. Arch Intern Med. 1995;155(15):1605-1609.
5. Dworkin RH, Schmader K. The epidemiology and natural history of herpes zoster and postherpetic neuralgia. In: Watson CPN, Gershon AA, eds. Herpes Zoster and Postherpetic Neuralgia. Vol 11. 2nd ed. Amsterdam, the Netherlands: Elsevier Science BV; 2001:39-64.
6. Edmunds WJ, Brisson M, Rose JD. The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales. Vaccine. 2001;19(23-24):3076-3090. (Pubitemid 32324035)
7. Gnann JW Jr, Whitley RJ. Clinical practice. Herpes zoster. N Engl J Med. 2002;347(5):340-346.
8. Insinga RP, Itzler RF, Pellissier JM, et al. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med. 2005;20(8):748-753. (Pubitemid 41141008)
9. de Melker H, Berbers G, Hahné S, et al. The epidemiology of varicella and herpes zoster in the Netherlands: implications for varicella zoster virus vaccination. Vaccine. 2006;24(18): 3946-3952.
10. Brisson M, Edmunds WJ. Epidemiology of varicella-zoster virus in England and Wales. J Med Virol. 2003;70(suppl 1): S9-S14. (Pubitemid 36368838)
11. Mullooly JP, Riedlinger K, Chun C, et al. Incidence of herpes zoster, 1997-2002. Epidemiol Infect. 2005;133(2):245-253. (Pubitemid 40439304)
12. Russell ML, Schopflocher DP, Svenson L, et al. Secular trends in the epidemiology of shingles in Alberta. Epidemiol Infect. 2007;135(6):908-913. (Pubitemid 47616471)
13. Pérez-Farinó s N, Ordobás M, Garća- Fernández C, et al. Varicella and herpes zoster in Madrid, based on the Sentinel General Practitioner Network: 1997-2004 [electronic article]. BMC Infect Dis. 2007;7:59. (doi:10.1186/1471-2334-7-59).
14. Yawn BP, Saddier P, Wollan PC, et al. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007; 82(11):1341-1349. (Pubitemid 350060129)
15. Tseng HF, Smith N, Harpaz R, et al. Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease. JAMA. 2011;305(2):160-166.
16. Yawn BP, Wollan PC, Kurland MJ, et al. Herpes zoster recurrences more frequent than previously reported. Mayo Clin Proc. 2011;86(2):88-93.
17. Yawn BP, Itzler RF, Wollan PC, et al. Health care utilization and cost burden of herpes zoster in a community population. Mayo Clin Proc. 2009;84(9):787-794.
18. Harpaz R, Ortega-Sanchez IR, Seward JF. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008; 57(RR-5):1-30. Quiz CE2-CE4.
19. Hornberger J, Robertus K. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Ann Intern Med. 2006;145(5):317-325. (Pubitemid 46768588)
20. Chapman RS, Cross KW, Fleming DM. The incidence of shingles and its implications for vaccination policy. Vaccine. 2003;21(19-20):2541-2547. (Pubitemid 36561347)
21. Thomas SL, Hall AJ. What does epidemiology tell us about risk factors for herpes zoster Lancet Infect Dis. 2004;4(1): 26-33. (Pubitemid 38057055)
22. Joesoef MR, Leung J, Harpaz R, et al. Potential coding error of herpes zoster (HZ) vaccination and HZ diagnosis in administrative data. Vaccine. 2011;29(11):2008-2009.
23. Fleming DM, Bartelds A, Chapman RS, et al. The consistency of shingles and its significance for health monitoring. Eur J Epidemiol. 2004;19(12):1113-1118. (Pubitemid 40228499)
24. Opstelten W, Mauritz JW, de Wit NJ, et al. Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database. Fam Pract. 2002;19(5): 471-475. (Pubitemid 35244231)
25. Czernichow S, Dupuy A, Flahault A, et al. Zona: enquête d'incidence chez les médecins généralistes du réseau "Sentinelles" [in French]. Ann Dermatol Venereol. 2001;128(4):497-501.
26. Rothberg MB, Virapongse A, Smith KJ. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Clin Infect Dis. 2007;44(10):1280-1288. (Pubitemid 46717289)
27. Horbar JD, Leahy KA. An assessment of data quality in the Vermont-Oxford Trials Network database. Control Clin Trials. 1995;16(1):51-61.
28. Sanjay S, Huang P, Lavanya R. Herpes zoster ophthalmicus. Curr Treat Options Neurol. 2011;13(1):79-91.
29. Lin HC, Chien CW, Ho JD. Herpes zoster ophthalmicus and the risk of stroke: a population-based follow-up study. Neurology. 2010;74(10):792-797.
30. Yawn BP, Yawn RA, Geier GR, et al. The impact of requiring patient authorization for use of data in medical records research. J Fam Pract. 1998;47(5):361-365. (Pubitemid 28541568)
31. Jacobsen SJ, Xia Z, Campion ME, et al. Potential effect of authorization bias on medical record research. Mayo Clin Proc. 1999;74(4):330-338. (Pubitemid 29162532)
32. Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc. 1996;71(3):266-274.
33. HICDA-Hospital International Classification of Diseases Adapted. All acronyms. March 21, 2011, 08:32. (http://www.allacronyms. com/HICDA/Hospital\ +International\+Classification\+ of\+Diseases\+Adapted/232167). (Accessed March 30, 2011).
34. ICD-9-CM-International Classification of Diseases-9th Revision-Clinical Modification. All acronyms. March 21, 2011, 08:41. (http://www.all-acronyms.com/ icd-9-cm/internationalclassificationofdiseases-9threvision-clinicalmodification/ 71836). (Accessed March 30, 2011).
35. Yawn BP, Wollan P. Interrater reliability: completing the methods description in medical records review studies. Am J Epidemiol. 2005;161(10):974-977. (Pubitemid 40656420)
36. Kantor J, Margolis DJ. The accuracy of using a wound care specialty clinic database to study diabetic neuropathic foot ulcers. Wound Repair Regen. 2000;8(3):169-173. (Pubitemid 30421519)
37. Leone MA, Capponi A, Varrasi C, et al. Accuracy of the ICD-9 codes for identifying TIA and stroke in an Italian automated database. Neurol Sci. 2004;25(5):281-288. (Pubitemid 40069183)
38. Riley M, Halliday J. The accuracy of eclampsia cases reported to the Victorian Inpatient Minimum Database and the Perinatal Data Collection Unit. Health Inf Manag. 1998;28(1):13-15.
39. Stergachis AS. Record linkage studies for postmarketing drug surveillance: data quality and validity considerations. Drug Intell Clin Pharm. 1988;22(2):157-161.
40. Woods CR. Impact of different definitions on estimates of accuracy of the diagnosis data in a clinical database. J Clin Epidemiol. 2001;54(8):782-788. (Pubitemid 32722181)
41. Roger VL, Weston SA, Redfield MM, et al. Trends in heart failure incidence and survival in a community-based population. JAMA. 2004;292(3):344-350. (Pubitemid 38944258)
42. Brisson M, Edmunds WJ, Gay NJ, et al. Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect. 2000;125(3):651-669. (Pubitemid 32156853)
43. Brisson M, Edmunds WJ. The cost-effectiveness of varicella vaccination in Canada. Vaccine. 2002;20(7-8): 1113-1125. (Pubitemid 34135947)
44. Pellissier JM, Brisson M, Levin MJ. Evaluation of the costeffectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Vaccine. 2007;25(49):8326-8337. (Pubitemid 350087379)
45. Kurland LT, Molgaard CA. The patient record in epidemiology. Sci Am. 1981;245(4):54-63.